MT-ND6 pseudogene 19 (MTND6P19)

MT-ND6 pseudogene 19 (MTND6P19) is a pseudogene in the human genome, related by sequence similarity to the functional mitochondrial ND6 gene that encodes a subunit of NADH:ubiquinone oxidoreductase (Complex I) in the mitochondrial inner membrane. While the true MT-ND6 gene has critical roles in mitochondrial electron transport and is implicated in disorders such as Leigh syndrome and Leber hereditary optic neuropathy[1][2][3], the pseudogene has no protein-coding potential and is not involved in therapeutic targeting. Its presence in the genome may be used for evolutionary or genomic studies, but it is not a receptor, enzyme, drug target, or disease biomarker. Most genetic databases and clinical guidelines do not ascribe direct biological or clinical significance to pseudogenes such as MTND6P19. The functional gene "MT-ND6" is involved in mitochondrial respiration and various diseases[1][2][3], but "MT-ND6 pseudogene 19" (MTND6P19) is not a therapeutic target. There are no drugs, biological functions, or disease associations specific to MTND6P19. If your goal is therapeutic or target information, refer to the functional MT-ND6 gene (not the pseudogene)[1][2][3].

Other names

MTND6P19MTND6 pseudogene 19mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6 pseudogene 19